CD70 and neoplasm: Based on the strong performance of CD70 CAR-TOAd−GFP cells in the NCG mouse tumor burden model, we established a high tumor burden model by intracranially injecting U251 cells into NCG mice (the mice in the control group had a survival time of about 20 days post-treatment).